We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$232M
AUM Growth
-$7.38M
Cap. Flow
-$16.7M
Cap. Flow %
-7.19%
Top 10 Hldgs %
29.39%
Holding
116
New
2
Increased
6
Reduced
34
Closed
9

Top Buys

Rank Stock Value
1
TVRD
Tvardi Therapeutics
TVRD
+$3.76M
2
RCKT icon
Rocket Pharmaceuticals
RCKT
+$523K
3
PVH icon
PVH
PVH
+$327K
4
CMCSA icon
Comcast
CMCSA
+$58.7K
5
NFLX icon
Netflix
NFLX
+$11.4K

Top Sells

Rank Stock Value
1
AGTC
Applied Genetic Technologies Corporation
AGTC
+$4.54M
2
QCOM icon
Qualcomm
QCOM
+$2.2M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$1.71M
4
KKR icon
KKR & Co
KKR
+$1.63M
5
MGNX icon
MacroGenics
MGNX
+$1.32M

Sector Composition

Rank Sector Weight
1 Healthcare 29.01%
2 Communication Services 22.71%
3 Energy 13.38%
4 Industrials 12.54%
5 Technology 5.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALL icon
26
Allstate
ALL
$65.9B
$3.53M 1.52%
56,845
-200
-0.4% -$12.4K
XOM icon
27
ExxonMobil
XOM
$644B
$3.37M 1.46%
43,247
– –
BAY
28
DELISTED
BAYER AG SPONS ADR
BAY
$3.31M 1.43%
26,284
– –
ETN icon
29
Eaton
ETN
$156B
$3.26M 1.41%
62,600
-370
-0.6% -$20K
UBA
30
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$3.25M 1.4%
168,999
– –
CVI icon
31
CVR Energy
CVI
$4.2B
$2.9M 1.25%
73,650
-200
-0.3% -$8.62K
EOG icon
32
EOG Resources
EOG
$75.2B
$2.73M 1.18%
38,551
– –
SNY icon
33
Sanofi
SNY
$107B
$2.66M 1.15%
62,364
– –
AGTC
34
DELISTED
Applied Genetic Technologies Corporation
AGTC
$2.62M 1.13%
128,377
-294,380
-70% -$4.54M
CEO
35
DELISTED
CNOOC Limited
CEO
$2.6M 1.12%
24,952
-100
-0.4% -$11.1K
PAA icon
36
Plains All American Pipeline
PAA
$18B
$2.53M 1.09%
109,473
-6,000
-5% -$162K
HCA icon
37
HCA Healthcare
HCA
$90.5B
$2.48M 1.07%
36,665
-50
-0.1% -$3.49K
ABBV icon
38
AbbVie
ABBV
$451B
$2.43M 1.05%
41,060
– –
CVX icon
39
Chevron
CVX
$396B
$2.27M 0.98%
25,175
– –
APA icon
40
APA Corp
APA
$14.9B
$2.24M 0.97%
50,400
-4,105
-8% -$191K
FWONK icon
41
Liberty Media Series C
FWONK
$25.5B
$2.23M 0.96%
82,888
– –
PRGO icon
42
Perrigo
PRGO
$2.01B
$2.07M 0.9%
14,336
-475
-3% -$73.1K
DT
43
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
$1.95M 0.84%
107,378
– –
CELG
44
DELISTED
Celgene Corp
CELG
$1.8M 0.78%
15,000
– –
QCOM icon
45
Qualcomm
QCOM
$175B
$1.77M 0.77%
35,512
-41,200
-54% -$2.2M
DVY icon
46
iShares Select Dividend ETF
DVY
$23.8B
$1.74M 0.75%
23,175
– –
RH icon
47
RH
RH
$2.83B
$1.66M 0.71%
20,830
– –
APC
48
DELISTED
Anadarko Petroleum
APC
$1.63M 0.71%
33,640
-14,814
-31% -$907K
GOOG icon
49
Alphabet (Google) Class C
GOOG
$4.19T
$1.58M 0.68%
41,580
– –
ABT icon
50
Abbott
ABT
$195B
$1.48M 0.64%
32,850
– –
1
2
3 4 5

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q4 2015 Portfolio in Review

As of Q4 2015, Private Capital Advisors held 116 positions worth $232M, down 3.1% from $239M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Private Capital Advisors withdrew a net $16.7M in Q4 2015, closing 9 positions and reducing 34 holdings. Its most notable exit was MacroGenics, an estimated $1.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Communication Services and Energy.

Against the trend, Private Capital Advisors opened a new position in Tvardi Therapeutics worth $4.16M.

  • Private Capital Advisors's largest Q4 2015 buy was Tvardi Therapeutics: 6,857 shares worth $4.16M.
  • Private Capital Advisors added most to Rocket Pharmaceuticals in Q4 2015, an estimated $523K increase.
  • Private Capital Advisors's biggest Q4 2015 reduction was Applied Genetic Technologies Corporation, cutting an estimated $4.54M.
  • Private Capital Advisors fully exited MacroGenics in Q4 2015, selling an estimated $1.32M.
  • Private Capital Advisors's ten largest holdings make up 29% of its $232M portfolio in Q4 2015.
  • Private Capital Advisors opened 2 new positions and closed 9 in Q4 2015.
  • Private Capital Advisors's portfolio value fell 3.1% quarter-over-quarter to $232M.

Based on Private Capital Advisors's 13F filing for Q4 2015, filed 22 Jan 2016.